The combination of these biomarkers ([TIMP-2]•[IGFBP7]) has been shown to be predictive of AKI in large diverse cohorts of critically ill patients in the Sapphire, Opal and Topaz studies [12–14]. Here, IGFBP7 is linked to acute kidney injury.